- Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
-
Banerjee R, Pal P, Nabi Z, Shava U, Ganesh G, Reddy DN
- KMID: 2521603
- Intest Res.
- 2021 Oct;19(4):398-407.
- doi: 10.5217/ir.2020.00107
Background/Aims: Information on pediatric inflammatory bowel disease (PIBD) and very early onset IBD (VEOIBD) are sparse in India, where IBD is emerging. We aimed to evaluate characteristics of VEOIBD and... -
- CITED
-
- Close
- SHARE
-
- Close
- Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
-
Banerjee R, Raja Ali RA, Wei SC, Adsul S
- KMID: 2508688
- Gut Liver.
- 2020 Nov;14(6):685-698.
- doi: 10.5009/gnl19209
The advent of biologics and biologic therapy has transformed the management of inflammatory bowel disease (IBD) with enhanced early and adequate responses to treatment, fewer hospitalizations, a reduced need for... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of H3K4me3-ChIP-Seq and RNA-Seq data to understand the putative role of miRNAs and their target genes in breast cancer cell lines
-
Kotipalli A, Banerjee R, Kasibhatla SM, Joshi R
- KMID: 2517578
- Genomics Inform.
- 2021 Jun;19(2):e17.
- doi: 10.5808/gi.21020
Breast cancer is one of the leading causes of cancer in women all over the world and accounts for ~25% of newly observed cancers in women. Epigenetic modifications influence differential... -
- CITED
-
- Close
- SHARE
-
- Close
- Achalasia Cardia Subtyping by High-Resolution Manometry Predicts the Therapeutic Outcome of Pneumatic Balloon Dilatation
-
Pratap N, Kalapala R, Darisetty , Joshi N, Ramchandani M, Banerjee R, Lakhtakia , Gupta R, Tandan M, Rao GV, Reddy DN
- KMID: 2326188
- J Neurogastroenterol Motil.
- 2011 Jan;17(1):48-53.
BACKGROUND/AIMS: High-resolution manometry (HRM) with pressure topography is used to subtype achalasia cardia, which has therapeutic implications. The aim of this study was to compare the clinical characteristics, manometric variables... -
- CITED
-
- Close
- SHARE
-
- Close
- Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
-
Singh A, Midha V, Narang V, Kedia S, Mahajan R, Dhoble P, Kahlon BK, Dhaliwal AS, Tripathi A, Kalra S, Jain NP, Bansal N, Banerjee R, Desai D, Dutta U, Ahuja V, Sood A
- KMID: 2547195
- Intest Res.
- 2023 Oct;21(4):452-459.
- doi: 10.5217/ir.2022.00087
Background/Aims: Primary sclerosing cholangitis (PSC) represents the most common hepatobiliary extraintestinal manifestation of inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD). Limited data exist on PSC... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
-
Banerjee R, Chuah SW, Hilmi IN, Wu DC, Yang SK, Demuth D, Lindner D, Adsul S
- KMID: 2512104
- Intest Res.
- 2021 Jan;19(1):83-94.
- doi: 10.5217/ir.2019.09160
Background/Aims: The efficacy and safety of vedolizumab in moderate-to-severely active Crohn’s disease (CD) were demonstrated in the GEMINI 2 study (NCT00783692). This post-hoc exploratory analysis aimed to assess the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Administration of Bacopa Monniera Increases BDNF Protein and mRNA Expressions: A Study in Chronic Unpredictable Stress Induced Animal Model of Depression
-
Banerjee R, Hazra S, Ghosh AK, Mondal AC
- KMID: 2316351
- Psychiatry Investig.
- 2014 Jul;11(3):297-306.
OBJECTIVE: The present study aimed to investigate whether graded doses of Bacopa Monniera (BM) extract could produce antidepressant-like effects in chronic unpredictable stress (CUS) induced depression in rats and its... -
- CITED
-
- Close
- SHARE
-
- Close
- Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior
-
Banerjee R, Pal P, Hutfless S, Ganesh BG, Reddy DN
- KMID: 2465814
- Intest Res.
- 2019 Oct;17(4):486-495.
- doi: 10.5217/ir.2018.00174
BACKGROUND/AIMS: Information about familial aggregation of inflammatory bowel disease (IBD) in Asia is limited. We aimed to analyze the prevalence and risk of familial IBD in an Indian cohort and... -
- CITED
-
- Close
- SHARE
-
- Close
- Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
-
Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A
- KMID: 2508562
- Intest Res.
- 2020 Oct;18(4):355-378.
- doi: 10.5217/ir.2019.09176
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of thiopurines in inflammatory bowel disease: an update
-
Singh A, Mahajan R, Kedia S, Dutta AK, Anand A, Bernstein CN, Desai D, Pai CG, Makharia G, Tevethia HV, Mak JW, Kaur K, Peddi K, Ranjan MK, Arkkila P, Kochhar R, Banerjee R, Sinha SK, Ng SC, Hanauer S, Verma S, Dutta U, Midha V, Mehta V, Ahuja V, Sood A
- KMID: 2525069
- Intest Res.
- 2022 Jan;20(1):11-30.
- doi: 10.5217/ir.2020.00155
Inflammatory bowel disease (IBD), once considered a disease of the Western hemisphere, has emerged as a global disease. As the disease prevalence is on a steady rise, management of IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach
-
Danese S, Banerjee R, Cummings J, Dotan I, Kotze PG, Leong RW, Paridaens , Peyrin-Biroulet L, Scott G, Assche GV, Wehkamp J, Yamamoto-Furusho JK
- KMID: 2434153
- Intest Res.
- 2018 Oct;16(4):522-528.
- doi: 10.5217/ir.2018.00073
Symptomatic ulcerative colitis (UC) can be a chronic, disabling condition. Flares in disease activity are associated with many of the negative impacts of mild-to-moderate UC. Rapid resolution of flares can... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 2: management
-
Park DI, Hisamatsu , Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK
- KMID: 2402643
- Intest Res.
- 2018 Jan;16(1):17-25.
- doi: 10.5217/ir.2018.16.1.17
Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in... -
- CITED
-
- Close
- SHARE
-
- Close
- Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: risk assessment
-
Park DI, Hisamatsu , Chen M, Ng SC, Ooi CJ, Wei SC, Banerjee R, Hilmi IN, Jeen YT, Han DS, Kim HJ, Ran Z, Wu K, Qian J, Hu PJ, Matsuoka K, Andoh A, Suzuki Y, Sugano K, Watanabe M, Hibi T, Puri AS, Yang SK
- KMID: 2402642
- Intest Res.
- 2018 Jan;16(1):4-16.
- doi: 10.5217/ir.2018.16.1.4
Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in... -
- CITED
-
- Close
- SHARE
-
- Close
- Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia
-
Ooi CJ, Hilmi I, Banerjee R, Chuah SW, Ng SC, Wei SC, Makharia G, Pisespongsa P, Chen MH, Ran ZH, Ye BD, Park DI, Ling KL, Ong D, Ahuja V, Goh KL, Sollano J, Lim WC, Leung WK, Ali RA, Wu DC, Ong E, Mustaffa N, Limsrivilai J, Hisamatsu , Yang SK, Ouyang Q, Geary R, De Silva J, Rerknimitr R, Simadibrata M, Abdullah M, Leong RW, on behalf of the Asia Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease and Asian Organization for Crohn's and Colitis
- KMID: 2454738
- Intest Res.
- 2019 Jul;17(3):285-310.
- doi: 10.5217/ir.2019.00026
The Asia-Pacific Working Group on inflammatory bowel disease (IBD) was established in Cebu, Philippines, under the auspices of the Asian Pacific Association of Gastroenterology with the goal of improving IBD... -
- CITED
-
- Close
- SHARE
-
- Close
